Kentucky Attorney General Sues GlaxoSmithKline for False Claims

Source: PharmaManufacturing.com

By Bruce Schreiner, AP

Feb 22, 2013

Kentucky's attorney general has joined in the flurry of legal action against GlaxoSmithKline, filing a lawsuit accusing the company of concealing the cardiovascular risks associated with a diabetes drug.

The suit claims that GlaxoSmithKline LLC violated the state's Consumer Protection Act by overstating the effectiveness of the prescription drug Avandia and hiding its risks from consumers. Instead of reducing cardiovascular risks faced by diabetics, as the drug maker claimed, the one-time blockbuster drug actually increases those risks, Attorney General Jack Conway said Thursday.

Read the full story